Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,364.80
(
3.49%
)
Dow Jones
46,584.46
(
0.00%
)
Brent Oil
90.75
(
-10.33%
)
Bitcoin
71,723.00
(
-0.37%
)
News Focus
News Focus
Post# of 11559
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

StocksDiva

Send PM Follow Ignore
Followers 377
Posts 20728
Boards Moderated 2
Alias Born 03/28/2010

StocksDiva

Re: StocksDiva post# 9617

Monday, 10/22/2012 7:12:16 AM

Monday, October 22, 2012 7:12:16 AM

Post# of 11559
Synergy Pharmaceuticals (SGYP) announced that on Oct 19, 2012 the co initiated oral dosing of healthy adult volunteers in a Phase I clinical trial of SP-333, a guanylate cyclase C (GC-C) agonist designed to treat ulcerative colitis.

http://finance.yahoo.com/news/synergy-pharmaceuticals-initiates-dosing-healthy-100000379.html

StocksDiva Bio Bin Board...Come say hi!!!



ALWAYS DO YOUR OWN DUE DILIGENCE!!! ALWAYS

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today